Skip to main content
Ensysce Biosciences, Inc. (ENSC)
NASDAQ: ENSC · Real-Time Price · USD
0.383
+0.000 (0.08%)
At close: Apr 28, 2026, 4:00 PM EDT
0.417
+0.034 (8.91%)
Pre-market: Apr 29, 2026, 7:04 AM EDT

Ensysce Biosciences Revenue

In the year 2025, Ensysce Biosciences had annual revenue of $5.07M, down -2.75%. Ensysce Biosciences had revenue of $1.88M in the quarter ending December 31, 2025, with 44.39% growth.

Revenue (ttm)
$5.07M
Revenue Growth
-2.75%
P/S Ratio
0.70
Revenue / Employee
$506,665
Employees
10
Market Cap
3.55M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20255.07M-143.38K-2.75%
Dec 31, 20245.21M2.98M133.58%
Dec 31, 20232.23M-292.86K-11.61%
Dec 31, 20222.52M-1.01M-28.54%
Dec 31, 20213.53M-400.01K-10.18%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
60 Degrees Pharmaceuticals 1.41M
SciSparc 1.31M
VivoSim Labs 142.00K
AIM ImmunoTech 88.00K
Azitra 7.50K
Revenue Rankings

ENSC News

More News